Insiders · Profile

Dipp Michelle

Chief Executive Officer at Tempest Therapeutics. Filing since 18 Nov 2013. CIK 0001551614

Company
Date
Role
Action
Shares
Amount
Of holding
1 Jun 2016
Chief Executive Officer
Bought
425,000
$2.98M
79.1%
18 May 2016
Chief Executive Officer
Bought
20,000
$157.20K
3.9%
17 May 2016
Chief Executive Officer
Bought
20,000
$151.20K
4.0%
16 May 2016
Chief Executive Officer
Bought
20,000
$153.80K
4.2%
13 May 2016
Chief Executive Officer
Bought
16,295
$115.04K
3.5%
12 May 2016
Chief Executive Officer
Bought
19,800
$135.35K
4.5%
11 May 2016
Chief Executive Officer
Bought
20,000
$152.80K
4.8%
10 May 2016
Chief Executive Officer
Bought
19,900
$153.63K
5.0%
24 Mar 2016
Chief Executive Officer
Bought
30,000
$276.91K
8.1%
23 Mar 2016
Chief Executive Officer
Bought
29,800
$290.33K
8.7%
22 Mar 2016
Chief Executive Officer
Bought
29,800
$313.92K
9.6%
21 Mar 2016
Chief Executive Officer
Bought
30,000
$310.59K
10.7%
18 Mar 2016
Chief Executive Officer
Bought
29,900
$260.74K
11.9%
17 Mar 2016
Chief Executive Officer
Bought
29,800
$232.22K
13.4%
16 Mar 2016
Chief Executive Officer
Bought
29,529
$228.30K
15.4%
15 Mar 2016
Chief Executive Officer
Bought
29,500
$237.80K
18.1%
14 Mar 2016
Chief Executive Officer
Bought
30,000
$241.60K
22.6%
11 Mar 2016
Chief Executive Officer
Bought
132,732
$995.49K
opened
24 Aug 2015
Chief Executive Officer
Bought
300
$5.57K
0.0%
26 May 2015
Chief Executive Officer
Bought
300
$9.31K
0.0%
2 Apr 2015
Chief Executive Officer
Bought
1,000
$32.49K
0.1%
24 Nov 2014
President and CEO
Bought
300
$7.36K
0.0%
28 Jul 2014
President and CEO
Bought
450
$4.05K
0.1%
23 Jun 2014
President and CEO
Bought
450
$3.91K
0.1%
19 May 2014
President and Chief Executive
Bought
450
$3.30K
0.1%
7 Mar 2014
President & CEO
Bought
100,000
$1.00M
2.7%
27 Jan 2014
President and CEO
Bought
300
$2.89K
0.0%
23 Dec 2013
President and CEO
Bought
600
$5.46K
0.1%
18 Nov 2013
President and CEO
Bought
400
$3.46K
0.0%
29 decisions on file.